Boneaid
Boneaid, licence 80095806: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- ENIGMA Boneaid
- Licence holder
- CANADIAN NEUTRICEUTICAL HEALTH INC.
- NPN or DIN-HM
- 80095806
- Status
- Active licence
- Licence date
- 28 November 2019
- Revision date
- 24 January 2020
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bore Source : Sodium borate | 700.0 mcg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 150.0 mg | 150,000 µg |
| Sélénium Source : Sélénite de sodium | 25.0 mcg | 25 µg |
| Calcium Source : Carbonate de calcium | 400.0 mg | 400,000 µg |
| Manganèse Source : Sulfate de manganèse (II) | 0.25 mg | 250 µg |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Croscarmellose de sodium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps (to) maintain/support immune function/system. Helps in the development and maintenance of bones and teeth. Helps in the development and maintenance of bones and teeth and maintain proper muscle function and tissue formation. Helps support bone health. Helps to build strong bones and teeth. Helps to produce and repair connective tissue. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80095806
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.